Cargando…
Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas
PURPOSE: The objective of this study was to compare the cost-effectiveness of preoperative octreotide therapy followed by surgery versus the standard treatment modality for growth-hormone secreting pituitary adenomas, direct surgery (that is, surgery without preoperative treatment) from a public thi...
Autores principales: | Caulley, Lisa, Krijkamp, Eline, Doyle, Mary-Anne, Thavorn, Kednapa, Alkherayf, Fahad, Sahlollbey, Nick, Dong, Selina X., Quinn, Jason, Johnson-Obaseki, Stephanie, Schramm, David, Kilty, Shaun J., Hunink, Myriam G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675692/ https://www.ncbi.nlm.nih.gov/pubmed/36030360 http://dx.doi.org/10.1007/s11102-022-01270-8 |
Ejemplares similares
-
Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
por: Fang, Hong-Juan, et al.
Publicado: (2017) -
TSH-secreting pituitary adenoma: benefits of pre-operative octreotide
por: Wallace, I R, et al.
Publicado: (2015) -
Prioritisation and design of clinical trials
por: Heath, Anna, et al.
Publicado: (2021) -
The effect of preoperative short-term octreotide treatment to surgery in thyrotropin-secreting pituitary adenomas: a retrospective cohort study
por: Zhao, Runsheng, et al.
Publicado: (2023) -
Complete Recovery of Sensorineural Hearing Loss Following Endoscopic Transsphenoidal Surgery for a Petrous Apex Cholesterol Granuloma: Case Report
por: Radonjic, Aleksandar, et al.
Publicado: (2019)